Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1997/010746external-prioritypatent/WO1998058927A1/en
Application filed by Baker Norton PharmafiledCriticalBaker Norton Pharma
Priority to NO996311ApriorityCriticalpatent/NO996311L/no
Publication of NO996311D0publicationCriticalpatent/NO996311D0/no
Publication of NO996311LpublicationCriticalpatent/NO996311L/no
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Nye 2'-oniumsalter av paklitaksel tjener som forlegemidler for pattedyrpasienter for å gi paklitaksel in vivo. Fremgangsmåtene for å syntetisere disse oniumsaltene er fremlagt i tillegg til fremgangsmåter for behandling av pasienter som lider av paklitaksel- mottagelige sykdommer ved administrering av effektiv mengder av oniumsaltene og farmasøytiske sammensetninger som inneholder de nye saltene som er egnet for administrasjon til pasienter som krever paklitakselbehandling.
NO996311A1997-06-201999-12-17Loeselige forlegemidler av paklitaksel
NO996311L
(no)
Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен
mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung
Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders